Oseltamivir Phosphate for Oral Suspension 6mg/ml recall — Class II (D-0327-2024) · pharmaranks
Class IITerminated
Oseltamivir Phosphate for Oral Suspension 6mg/ml recall
FDA recall D-0327-2024 · initiated Feb 13, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Failed Impurities/Degradation Specifications: Out-of-specification test results.
Details
Product
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6
Recalling company
Amneal Pharmaceuticals of New York, LLC
Classification
Class II
Status
Terminated
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Feb 13, 2024
FDA report date
Feb 28, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.